Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Magnum Ice Cream Company N.V. Ordinary Shares (MICC) vs Tango Therapeutics Inc. (TNGX) Price & Performance

The Magnum Ice Cream Company N.V. Ordinary SharesTrade
Tango Therapeutics Inc.Trade

Price performance (Past 24H)

Key statistics

The Magnum Ice Cream Company N.V. Ordinary Shares vs Tango Therapeutics Inc. — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.98B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is far larger — about 2.9× Tango Therapeutics Inc.'s market cap, and The Magnum Ice Cream Company N.V. Ordinary Shares is trading nearer its 52-week high, Tango Therapeutics Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Tango Therapeutics Inc. for 0 Days on average.

MICCTNGX
Market Cap
$10.98B$3.74B
Volume
789,3083,438,781
Sector
Consumer StaplesHealth
52-Week High
$20.42$32.90
52-Week Low
$13.06$7.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$14.41B$2.76B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Magnum Ice Cream Company N.V. Ordinary Shares

No Aura AI signal available yet.

Tango Therapeutics Inc.

TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.

Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MICC
100% Buy0% Sell
Avg holding period · 0 Days
TNGX
100% Buy0% Sell
Avg holding period · 0 Days

About The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.

Read more on MICC →

About Tango Therapeutics Inc.

Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.

Read more on TNGX →